1st Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,840,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 19, 2021 $1,840,000 Replaced
1st Quarter - Amendment Apr 19, 2021 $1,840,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Hospital discounts; 340B program

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Justice, Dept of (DOJ); Commerce, Dept of (DOC); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Immigration IMM

Administration Immigration Proclamation on non-immigrant visa categories

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); State, Dept of (DOS); Office of Management & Budget (OMB); SENATE; Justice, Dept of (DOJ); Homeland Security, Dept of (DHS)

Copyright/Patent/Trademark CPT

Prescription Drug Pricing Reduction Act (PDPRA - S.4199); Pharmaceutical intellectual property issues; Consolidated Appropriations Act 2021 (HR.133)

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS)

Bills named: H.R. 133 (117th), S. 4199 (117th)

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-Kenta, and US-Brazil

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK New —
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Food & Drug Administration (FDA); State, Dept of (DOS); SENATE; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; Pension and retirement benefit issues; Consolidated Appropriations Act, 2021 (HR.133)

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Executive Office of the President (EOP); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR); Homeland Security, Dept of (DHS); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 133 (117th)

Health Issues HCR

Patient protection; Drug supply chain and shortages; Drug pricing, value and access; Transparency; Intellectual property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act"; Consolifdated Act 2021 (HR 13)

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Office of Management & Budget (OMB); State, Dept of (DOS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES

Bills named: H.R. 13 (117th)

Medicare/Medicaid MMM

Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage and value; Prescription Drug Pricing Reduction Act (PDPRA - S.4199); Developing an Innovative Strategy for Antimicrobial Resistant Microorganism Act of 2019 (DISARM Act - S.1712); Consolidated Appropriations Act, 2021 (HR.133)

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: SENATE; Justice, Dept of (DOJ); Executive Office of the President (EOP); Office of Management & Budget (OMB); State, Dept of (DOS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Bills named: S. 1712 (117th), H.R. 133 (117th), S. 4199 (117th)

Consumer Issues/Safety/Products CSP

Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); SENATE; U.S. Trade Representative (USTR); Homeland Security, Dept of (DHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.